SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001437749-21-027622
Filing Date
2021-12-01
Accepted
2021-12-01 16:05:25
Documents
16
Period of Report
2021-11-05
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A nby20211130_8ka.htm   iXBRL 8-K/A 37060
2 EXHIBIT 23.1 ex_311599.htm EX-23.1 3774
3 EXHIBIT 99.2 ex_311600.htm EX-99.2 109421
4 EXHIBIT 99.3 ex_311601.htm EX-99.3 315285
  Complete submission text file 0001437749-21-027622.txt   638254

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA nby-20211105.xsd EX-101.SCH 3585
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nby-20211105_def.xml EX-101.DEF 12172
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE nby-20211105_lab.xml EX-101.LAB 16369
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nby-20211105_pre.xml EX-101.PRE 12442
9 EXTRACTED XBRL INSTANCE DOCUMENT nby20211130_8ka_htm.xml XML 2790
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

IRS No.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-33678 | Film No.: 211462921
SIC: 2834 Pharmaceutical Preparations